Market Newsdesk

NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that purchased Biogen, Inc. (NASDAQ: BIIB) securities between October 22, 2019 and November 6, 2020 (the “Class Period”). Investors have until January 12, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

On November 6, 2020, Reuters published an article entitled “FDA advisory panel convenes to discuss whether Biogen Alzheimer’s drug should be approved” which stated that “Biogen shares were halted ahead of the advisory panel meeting.” Later on November 6, 2020, Reuters published an article entitled “U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer’s drug.”

On this news, Biogen’s stock price fell $92.64 per share, or 28%, to close at $236.26 per share on November 9, 2020, the next trading day.

The complaint, filed on November 13, 2020, alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab’s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you purchased Biogen securities during the Class Period and suffered a loss, are a long term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About
Bragar
Eagel
& Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com

NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors that purchased Interface, Inc. (NASDAQ: TILE) securities between March 2, 2018 and September 28, 2020 (the “Class Period”). Investors have until January 11, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

On April 24, 2019, Defendants filed a current report on Form 8-K with the SEC, disclosing, inter alia, that Interface “received a letter in November 2017 from the [SEC] requesting that the Company voluntarily provide information and documents in connection with an investigation into the Company’s historical quarterly [EPS] calculations and rounding practices during the period 2014-2017”; that “[t]he Company subsequently received subpoenas from the SEC in February 2018, July 2018 and April 2019 requesting additional documents and information”; and that “[i]n the fourth quarter of 2018, the Company conducted at the SEC’s request an internal investigation into these and other related issues for seven quarters in 2015, 2016 and 2017.”

On this news, Interface’s stock price fell $1.43 per share, or 8.37%, to close at $15.66 per share on April 25, 2019.

Then, on September 28, 2020, the SEC announced the conclusion of its investigation into Interface’s historical quarterly EPS calculations and rounding practices. Interface agreed to pay a $5 million fine to resolve the matter and was ordered to cease and desist from violating the federal securities laws. In the SEC’s enforcement order issued that same day, the SEC also disclosed how, inter alia, “Interface employees caused Interface to produce documents in response to Commission investigative requests that were suggestive of contemporaneous support for journal entries that, in truth, did not exist at the time the entries were recorded,” and had modified certain documents after the SEC’s investigation began.

On this news, Interface’s stock price fell $0.20 per share, or 3.13%, over the following two trading sessions to close at $6.18 per share on September 29, 2020.

The complaint, filed on November 12, 2020, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share (“EPS”) in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the Securities and Exchange Commission (“SEC”) with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC’s investigation, and downplayed the true scope of the Company’s wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you purchased Interface securities during the Class Period and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About
Bragar
Eagel
& Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com

VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Liberty Gold Corp. (LGD – TSX) (“Liberty Gold” or the “Company”), is pleased to announce its financial and operating results for the nine months ended September 30, 2020. All amounts are presented in United States dollars (“USD”) unless otherwise stated.

Liberty Gold is focused on advancing a pipeline of Carlin-Style gold deposits in the Great Basin, U.S.A., a mining-friendly jurisdiction that is home to large-scale oxide gold systems ideal for open-pit heap leach mining. The Great Basin covers portions of the states of Nevada, Utah and Idaho. The Company has a proven track-record in discovery and building value in this region.

HIGHLIGHTS:

• Liberty Gold announced the closing of the sale of the Halilağa porphyry copper gold deposit in Turkey, and receipt of the first of the three staged payments of $6.0 million. A further two $6.0 million installments are bank guaranteed and will be received on August 15, 2021 and August 15, 2022 respectively¹.
• Contributing towards Liberty Gold’s cash balance of $16.7 million held as at today’s date, since January 1, 2020, to the date of this release, we have received a total of C$3.4 million and C$1.4 million from the early exercise of Liberty Gold common share purchase warrants  (“Warrants”) issued pursuant to the bought deal financings that closed on October 2, 2018 and January 26, 2018, respectively; the Warrants are exercisable for C$0.60 and C$0.65, respectively, for a period of three years from issue.
• In August 2020 we announced the start of a five-hole core drill program at the TV Tower property in Turkey.
• Continuing the monetisation of non-core assets, on November 12, 2020, pursuant to an option agreement on the Baxter Spring gold project (“Baxter Option Agreement”), between Liberty Gold and Huntsman Exploration Inc. (TSXV:HMAN, formerly BlueBird Battery Metals Inc.) (“Huntsman”), Liberty Gold received $250,000 in cash and 14,986,890 common shares in Huntsman (“Huntsman Shares”) equal to 19.5% of the issued and outstanding Huntsman Shares², subject to a 12 month hold period. Pursuant to the Baxter Option Agreement, a final payment of $250,000 is due on November 12, 2021. In addition, Liberty Gold will retain a 2% Net Smelter Royalty and back-in rights to acquire up to a 35% interest in Baxter Spring within three years, upon payment of the sum of $1.0 million to Huntsman. Liberty Gold also retains the right to appoint a member to Huntsman’s board of directors provided minimum share positions are maintained per the terms outlined in the Baxter Option Agreement.

At Black Pine we:

• Reported weighted average 82.9% gold extraction in phase 2 of metallurgical column testing, with a range up to 94.5% gold extraction.³
• Released further results from drilling at the D-1 zone. Highlights include:
  – 1.26 grams per tonne gold (“g/t Au”) over 10.7 metres (“m”), including 1.59 g/t Au over 7.6 m in LBP176.
  – 1.18 g/t Au over 16.8 m including 1.82 g/t Au over 7.6 m in LBP173.
  – 1.06 g/t Au over 32.0 m including 2.34 g/t Au over 10.7 m in LBP168.
• Continue to intersect high-grade oxide gold in the D-3 zone, discovered in close proximity to the D-1 and D-2 zones and accretive to the overall gold endowment in the Black Pine gold system. Highlights include⁴:
  – 0.98 g/t Au over 80.8 m including 2.32 g/t Au over 18.3 m and including 5.60 g/t Au over 3.0 m, and 2.19 g/t Au over 7.6 m including 3.17 g/t Au over 4.6 m in LBP169.
  – 0.86 g/t Au over 9.1 m and 0.82 g/t Au over 33.5 m, including 1.28 g/t Au over 16.8 m in LBP162.
  – 1.50 g/t Au over 27.4 m and 0.62 g/t Au over 7.6 m in LBP203.
  – 1.10 g/t Au over 15.2 m, including 1.63 g/t Au over 7.6 m and 0.70 g/t Au over 44.2 m including 1.77 g/t Au over 3.0 m and 1.68 g/t Au over 4.6 m in LBP165.

SELECTED FINANCIAL DATA

The following selected financial data is derived from our unaudited condensed interim financial statements and related notes thereto (the “Interim Financial Statements”) for the three and nine months ended September 30, 2020 as prepared in accordance with International Accounting Standards – IAS 34: Interim Financial Statements.

A copy of the Interim Financial Statements is available on the Company’s website at www.libertygold.ca or on SEDAR at www.sedar.com.

The information in the tables below is presented in $000s in USD except per share data:

	Three months ended September 30 ,					Nine months ended September 30 ,
	20 20		201 9			20 20		20 19
Attributable to shareholders:
Income (loss) for the period	$	12,866	$	(2,931	)	$	10,705	$	(7,182	)
Income (loss) and comprehensive income (loss) for the period	$	13,386	$	(3,128	)	$	10,527	$	(7,143	)
Basic and diluted income (loss) per share	$	0.05	$	(0.01	)	$	0.04	$	(0.03	)

	As at September 30 ,		As at December 31,
	2020		2019
Cash and short-term investments	$	17,496	$	14,464
Working capital	$	18,235	$	11,493
Total assets	$	57,644	$	42,109
Current liabilities	$	5,879	$	5,403
Non-current liabilities	$	2,405	$	1,998
Shareholders’ equity	$	41,501	$	26,192

ABOUT
LIBERTY
GOLD

Liberty Gold is focused on exploring the Great Basin of the United States, home to large-scale gold projects that are ideal for open-pit mining.  This region is one of the most prolific gold-producing regions in the world and stretches across Nevada and into Idaho and Utah.  We know the Great Basin and are driven to discover and advance big gold deposits that can be mined profitably in open-pit scenarios.  Our flagship projects are Black Pine in Idaho and Goldstrike in Utah, both past-producing open-pit mines, where previous operators only scratched the surface

For more information, visit www.libertygold.ca or contact:

Susie Bell, Manager, Investor Relations

Phone: 604-632-4677 or Toll Free 1-877-632-4677
[email protected]

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to Liberty Gold within the meaning of applicable securities laws, including statements that address potential quantity and/or grade of minerals, potential size and expansion of a mineralized zone, proposed timing of exploration and development plans
.
Forward-looking information is often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “planned”, “expect”, “project”, “predict”, “potential”, “targeting”, “intends”, “believe”, “potential”, and similar expressions, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “should”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management at the date the statements are made including, among others, assumptions about future prices of gold, and other metal prices, currency exchange rates and interest rates, favourable operating conditions, political stability,
including any impacts due to the recent pandemic of the novel coronavirus (COVID-19),
obtaining governmental approvals and
any
financing on time,
the receipt of future staged payments
relating to the option on
Baxter Spring
and on the sale of Halilağa
,
obtaining renewals for existing licenses and permits and obtaining required licenses and permits, labour stability, stability in market conditions, availability of equipment, accuracy of any mineral resources, the availability of drill rigs, the accuracy of a
preliminary economic assessment, successful resolution of disputes and anticipated costs and expenditures. Many assumptions are based on factors and events that are not within the control of Liberty Gold and there is no assurance they will prove to be correct.

Such forward-looking information, involves known and unknown risks, which may cause the actual results to be materially different from any future results expressed or implied by such forward-looking information, including, risks related to the interpretation of results and/or the reliance on technical information provided by third parties as related to the Company’s mineral property interests; changes in project parameters as plans continue to be refined; current economic conditions; future prices of commodities; possible variations in grade or recovery rates; the costs and timing of the development of new deposits; failure of equipment or processes to operate as anticipated; the failure of contracted parties to perform; the timing and success of exploration activities generally; delays in permitting;
including any restrictions due to the recent pandemic of the novel coronavirus (COVID-19),
possible claims against the Company; labour disputes and other risks of the mining industry; delays in obtaining governmental approvals, financing
,
or in the completion of exploration
,
as well as those factors discussed in the Annual Information Form of the Company dated
March 2
6
, 20
20
in the section entitled “Risk Factors”, under Liberty Gold’s SEDAR profile at 

www.sedar.com

.

Although Liberty Gold has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Liberty Gold disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law
.

¹ See press release dated August 12, 2020
² See press release dated September 29, 2020
³ See press release dated August 18, 2020
⁴  See press release dated September 10, 2020 and November 10, 2020

IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19.

Presentation Details

Date: Thursday, November 19
Time: 11:10 AM GMT/ 6:10 AM EST/ 3:10 AM PST
Webcast:https://wsw.com/webcast/jeff141/tars/1861050

The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days.

In addition to the presentation, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Tarsus should contact their Jefferies representative.

About Tarsus Pharmaceuticals, Inc.
 

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis. For more information, please visit www.tarsusrx.com.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words, without limitation, “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms of the offering or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus that forms a part of the effective registration statement filed with the SEC. Any forward-looking statements contained in this press release are based on the current expectations of Tarsus’ management team and speak only as of the date hereof, and Tarsus specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Media Contact:

Allison Howell
Pascale Communications, LLC
[email protected]

ROAD TOWN, British Virgin Islands, Nov. 13, 2020 (GLOBE NEWSWIRE) — Aura Minerals, Inc. (“Aura Minerals” or the “Company”) announces that the Company has filed today its interim financial statements for the third quarter of 2020, its associated management’s discussion and analysis and related certification filings for the third quarter of 2020 (collectively, the “Third Quarter Results”).

Rodrigo Barbosa, CEO of Aura, comments: “We at Aura are very pleased with both our quarterly results and the new trajectory for the company. Not only did we start this quarter with a successful IPO in Brazil, significantly strengthening our balance sheet and our support base, but also we delivered on our promises: Stronger production, lower cost and continued profit growth. Today, we published another record high result for Aura. Our team was able to achieve these results while also focusing on the safety of our employees, rigorously implementing procedures to avoid spread of COVID-19 within our operations, allowing us to resume near full production in our operations. The Q3 results shows that we continue to increase production when compared to Q4 2019 (pre-COVID-19 impacts) and to reduce costs. Moreover, we expect to continue to generate future growth by advancing several projects in our portfolio and adding more production during Q4 and the years to come.”

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements”, as defined in applicable Canadian securities laws (collectively, “forward-looking statements”) which include, but are not limited to, future development of the Company’s projects and increases in production.

Known and unknown risks, uncertainties and other factors, many of which are beyond the Company’s ability to predict or control, could cause actual results to differ materially from those contained in the forward-looking statements. Specific reference is made to the most recent Annual Information Form on file with certain Canadian provincial securities regulatory authorities for a discussion of some of the factors underlying forward-looking statements.

All forward-looking statements herein are qualified by this cautionary statement. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements whether as a result of new information or future events or otherwise, except as may be required by law. If the Company does update one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements.

About Aura 360° Mining

Aura is focused on mining in complete terms – thinking holistically about how its business impacts and benefits every one of our stakeholders: our company, our shareholders, our employees, and the countries and communities we serve. We call this 360° Mining.

Aura is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The Company’s producing assets include the San Andres gold mine in Honduras, the Ernesto/Pau-a -Pique gold mine in Brazil, the Aranzazu copper-gold-silver mine in Mexico and Gold Road mine in the United States. In addition, the Company has two additional gold projects in Brazil, Almas and Matupá, and one gold project in Colombia, Tolda Fria.

For further information, please visit Aura’s website at www.auraminerals.com or contact:

Rodrigo Barbosa                 
President & CEO                
305-239-9332